Sevgi Kurt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sevgi Kurt has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Cetin Ordu
Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey
3 shared publications - Enver Özkurt
Demiroğlu Science University School of Medicine, Department of General Surgery, Istanbul, Turkiye; Istanbul Florence Nightingale Hospital, Istanbul, Turkiye
3 shared publications - Filiz Çelebi
Yeditepe Univ, Fac Med, Dept Radiol, Istanbul, Turkiye
3 shared publications - Isil Akgun Demir
Department of Plastic, Reconstructive and Aesthetic Surgery, Istanbul Atlas University, Istanbul, Turkey
3 shared publications - Vahit Ozmen
Department of Surgery, Head of Breast Surgery Unit Istanbul Florence Nightingale Hospital Istanbul Türkiye
3 shared publications - Ahmet Serkan Ilgun
Specialist Breast and General Surgeon, Department of General and Vascular Surgery, Mater Dei Hospital, St. Paul’s Bay, Malta
2 shared publications
Latest Publications
- 12 October 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- p. 1-7
Three-Dimensional Surface Imaging in Postoperative Volumetric Assessment of Implant-Only and Composite Breast Augmentation
Background Three-dimensional (3D) surface imaging is better validated for postoperative volume assessment in implant-only augmentation than in composite breast augmentation (CBA). In CBA, the extent to which anatomical features and biological variability contribute to volumetric deviation remains insufficiently defined. Methods This retrospective study included 94 patients (188 breasts) who underwent either implant-only augmentation (Group 0) or composite augmentation with fat grafting (Group 1). Breast volumes were measured with the Vectra XT system preoperatively and at 3 and 6 months postoperatively. Net postoperative volume gain was compared with implant volume, and both signed and absolute volumetric deviations were calculated. Mixed-effects and generalized estimating equation models were used to identify factors associated with deviation magnitude and direction. Results Six-month postoperative breast volume was greater in the composite group than in the implant-only group (p = 0.0186). Signed volumetric deviation was significantly more negative in composite cases (p < 0.001). A net volume gain smaller than implant volume was observed in 20.9% of composite breasts and 48.0% of implant-only breasts (p < 0.001). Among breasts with a net gain smaller than implant volume, the median deviation magnitude was similar in both groups, at approximately 22 mL. Greater breast base width was independently associated with increased absolute volumetric deviation (p = 0.005), whereas intersternal distance influenced deviation direction but not deviation magnitude. Postoperative BMI change was also independently associated with signed volumetric deviation (p < 0.001). Agreement between 3- and 6-month measurements was high (ICC = 0.95). Conclusions Vectra XT showed stable postoperative volumetric tracking after implant-only breast augmentation and may also be useful for follow-up assessment in composite cases. In composite augmentation, variations from the theoretically expected volume appear to reflect biological variability in fat graft retention and anatomical footprint rather than instability of the imaging system. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 12 October 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- p. 1-7
Three-Dimensional Surface Imaging in Postoperative Volumetric Assessment of Implant-Only and Composite Breast Augmentation
Background Three-dimensional (3D) surface imaging is better validated for postoperative volume assessment in implant-only augmentation than in composite breast augmentation (CBA). In CBA, the extent to which anatomical features and biological variability contribute to volumetric deviation remains insufficiently defined. Methods This retrospective study included 94 patients (188 breasts) who underwent either implant-only augmentation (Group 0) or composite augmentation with fat grafting (Group 1). Breast volumes were measured with the Vectra XT system preoperatively and at 3 and 6 months postoperatively. Net postoperative volume gain was compared with implant volume, and both signed and absolute volumetric deviations were calculated. Mixed-effects and generalized estimating equation models were used to identify factors associated with deviation magnitude and direction. Results Six-month postoperative breast volume was greater in the composite group than in the implant-only group (p = 0.0186). Signed volumetric deviation was significantly more negative in composite cases (p < 0.001). A net volume gain smaller than implant volume was observed in 20.9% of composite breasts and 48.0% of implant-only breasts (p < 0.001). Among breasts with a net gain smaller than implant volume, the median deviation magnitude was similar in both groups, at approximately 22 mL. Greater breast base width was independently associated with increased absolute volumetric deviation (p = 0.005), whereas intersternal distance influenced deviation direction but not deviation magnitude. Postoperative BMI change was also independently associated with signed volumetric deviation (p < 0.001). Agreement between 3- and 6-month measurements was high (ICC = 0.95). Conclusions Vectra XT showed stable postoperative volumetric tracking after implant-only breast augmentation and may also be useful for follow-up assessment in composite cases. In composite augmentation, variations from the theoretically expected volume appear to reflect biological variability in fat graft retention and anatomical footprint rather than instability of the imaging system. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 1 May 2026
- Published by Atlas Universitesi Tip ve Saglik Bilimleri Dergisi in Atlas Universitesi Tip ve Saglik Bilimleri Dergisi
Meme kanseri cerrahisinde onkoplastik ve rekonstrüktif yaklaşımlar: güncel pratik ve teknikler
Günümüzde ileri evre ve hatta metastatik meme kanseri vakaları hâlâ görülmektedir. Ancak gelişmiş görüntüleme ve tanı yöntemleri sayesinde erken tanı konulabilmekte, genetik testler sayesinde riskli hastalara profilaktik mastektomi kararı alınarak risk azaltılabilmektedir. Kadınların hem fiziksel hem ruhsal sağlığı açısından meme bütünlüğünün korunması büyük önem taşır. Uygun hastalarda meme koruyucu cerrahi tercih edilip memenin orijinal yapısı büyük ölçüde korunurken, daha büyük rezerksiyonlar veya memenin tamamının alınması gerektiği durumlarda rekonstrüktif seçenekler devreye girer. Bu derlemede meme rekonstrüksiyonunun tarihsel süreci, onkoplastik ve rekonstrüktif cerrahideki tekniklerin evrimiyle beraber karşılaşılabilecek komplikasyonlar ve multidisipliner yaklaşımın önemi tartışılmıştır. Modern onkoplastik ve rekonstrüktif yaklaşımlar, meme kanseri sonrası hastaların anatomik ve estetik bütünlüğünü sağlayarak yaşam kalitelerinin arttırılmasında önemli bir rol oynar.
- 1 May 2026
- Published by Atlas Universitesi Tip ve Saglik Bilimleri Dergisi in Atlas Universitesi Tip ve Saglik Bilimleri Dergisi
Meme kanseri cerrahisinde onkoplastik ve rekonstrüktif yaklaşımlar: güncel pratik ve teknikler
Günümüzde ileri evre ve hatta metastatik meme kanseri vakaları hâlâ görülmektedir. Ancak gelişmiş görüntüleme ve tanı yöntemleri sayesinde erken tanı konulabilmekte, genetik testler sayesinde riskli hastalara profilaktik mastektomi kararı alınarak risk azaltılabilmektedir. Kadınların hem fiziksel hem ruhsal sağlığı açısından meme bütünlüğünün korunması büyük önem taşır. Uygun hastalarda meme koruyucu cerrahi tercih edilip memenin orijinal yapısı büyük ölçüde korunurken, daha büyük rezerksiyonlar veya memenin tamamının alınması gerektiği durumlarda rekonstrüktif seçenekler devreye girer. Bu derlemede meme rekonstrüksiyonunun tarihsel süreci, onkoplastik ve rekonstrüktif cerrahideki tekniklerin evrimiyle beraber karşılaşılabilecek komplikasyonlar ve multidisipliner yaklaşımın önemi tartışılmıştır. Modern onkoplastik ve rekonstrüktif yaklaşımlar, meme kanseri sonrası hastaların anatomik ve estetik bütünlüğünü sağlayarak yaşam kalitelerinin arttırılmasında önemli bir rol oynar.
- Open Access
- 14 April 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (6) , 1396-1405
Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
Introduction: Achieving a pCR serves as a biomarker indicating enhanced overall survival for breast cancer patients undergoing NST. Vitamin D enhances the antitumor effect of chemotherapeutics as demonstrated in cancer cells and animal models. In this prospective randomized clinical study, we aim to investigate the effect of oral vitamin D supplementation during neoadjuvant systemic therapy (NST) on pathologic complete response (pCR). Methods: Between June 2019 and June 2023, an oral form of 50,000 IU vitamin D3 (cholecalciferol) replacement was administered once a week during NST for the study group. Results: There were 114 (50.2%) cases in the study group and 113 (49.8%) in the control group (totally 227 cases). Factors that positively influenced pCR were higher clinical T stage, higher AJCC clinical stage, Estrogen receptor negativity, progesterone receptor negativity, human epidermal growth factor receptor 2 positivity, high Ki‐67 expression (≥ 20%), hormone negative molecular subtypes, and vitamin D intake in univariate analysis. In the multivariate analysis, factors significantly affecting pCR were vitamin D intake (OR: 2.33, 95% CI 1.20–4.53; p = 0.013), hormone receptor negativity (OR: 2.22, 95% CI 1.11–4.43; p = 0.024), and Ki‐67 ≥ 20% (OR: 3.27, 95% CI 1.03–10.34; p = 0.044). Conclusions: This is the first and only study to compare the effect of oral vitamin D supplementation on pCR during NST. Vitamin D supplementation during NST has a significant effect on pCR in breast cancer patients. Although this effect is not significant for axillary pCR, there is an almost significant correlation. Trial Registration: ClinicalTrials.gov (Identifier: NCT03986268)
- 14 April 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (6) , 1396-1405
Open AccessVitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
Introduction: Achieving a pCR serves as a biomarker indicating enhanced overall survival for breast cancer patients undergoing NST. Vitamin D enhances the antitumor effect of chemotherapeutics as demonstrated in cancer cells and animal models. In this prospective randomized clinical study, we aim to investigate the effect of oral vitamin D supplementation during neoadjuvant systemic therapy (NST) on pathologic complete response (pCR). Methods: Between June 2019 and June 2023, an oral form of 50,000 IU vitamin D3 (cholecalciferol) replacement was administered once a week during NST for the study group. Results: There were 114 (50.2%) cases in the study group and 113 (49.8%) in the control group (totally 227 cases). Factors that positively influenced pCR were higher clinical T stage, higher AJCC clinical stage, Estrogen receptor negativity, progesterone receptor negativity, human epidermal growth factor receptor 2 positivity, high Ki‐67 expression (≥ 20%), hormone negative molecular subtypes, and vitamin D intake in univariate analysis. In the multivariate analysis, factors significantly affecting pCR were vitamin D intake (OR: 2.33, 95% CI 1.20–4.53; p = 0.013), hormone receptor negativity (OR: 2.22, 95% CI 1.11–4.43; p = 0.024), and Ki‐67 ≥ 20% (OR: 3.27, 95% CI 1.03–10.34; p = 0.044). Conclusions: This is the first and only study to compare the effect of oral vitamin D supplementation on pCR during NST. Vitamin D supplementation during NST has a significant effect on pCR in breast cancer patients. Although this effect is not significant for axillary pCR, there is an almost significant correlation. Trial Registration: ClinicalTrials.gov (Identifier: NCT03986268)
- Open Access
- 8 January 2025
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 7, ojaf157
Real- vs High-Definition Ultrasound-Assisted Liposuction in Men: Long-Term Outcomes and the Role of Helium Plasma Skin Tightening
Background: Male body contouring has evolved from conventional debulking to high-definition liposuction (HDL) etching and, more recently, a “real-definition” c (RDL) approach emphasizing natural contours. The role of helium-plasma skin tightening (HPST) as an adjunct remains uncertain. Objectives: To compare long-term patient-reported outcomes, complications, and revision rates between RDL and HDL in men undergoing ultrasound-assisted liposuction (UAL), and to evaluate the selective role of HPST in improving skin quality. Methods: A retrospective analysis was performed on 743 male patients who underwent primary UAL between 2008 and 2024. Patients were grouped by era: conventional (2008-2011), HDL (2011-2014), RDL (2015-2019), and RDL with HPST (2019-2024). Outcomes included BODY-Q satisfaction, complication severity, and revision rates. Regression, mediation, and propensity-score matching analyses were applied to identify predictors of durable satisfaction and recommendation. Results: Mean satisfaction improved across eras: 59.3 (2008-2011), 57.7 (2011-2014), 66.8 (2015-2019), and 73.8 (2019-2024). HDL patients showed the lowest durable scores despite high early ratings and were most associated with self-reported “fake abs,” which correlated with reduced BODY-Q domains. RDL produced more stable outcomes, particularly in men with BMI ≤25 and ≥4 exercise sessions/week. Sports frequency predicted higher satisfaction directly and indirectly via lower body mass index (BMI). Clinically meaningful complications declined from 15.4% to 4.6% across eras. Helium-plasma skin tightening was offered mainly to older, higher-BMI men and, after adjustment, was not independently associated with improved skin quality. RDL was linked to a lower revision risk (odds ratio (OR) 0.32, P = .029). Conclusions: Real-definition liposuction provided natural, durable outcomes and fewer revisions than HDL. Over-etching increased unnatural contours and dissatisfaction. Careful patient selection—BMI ≤25, consistent exercise, and weight stability—is critical, while HPST may be reserved for older men with mild laxity. Level of Evidence: 3 (Therapeutic):
- 8 January 2025
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 7, ojaf157
Open AccessReal- vs High-Definition Ultrasound-Assisted Liposuction in Men: Long-Term Outcomes and the Role of Helium Plasma Skin Tightening
Background: Male body contouring has evolved from conventional debulking to high-definition liposuction (HDL) etching and, more recently, a “real-definition” c (RDL) approach emphasizing natural contours. The role of helium-plasma skin tightening (HPST) as an adjunct remains uncertain. Objectives: To compare long-term patient-reported outcomes, complications, and revision rates between RDL and HDL in men undergoing ultrasound-assisted liposuction (UAL), and to evaluate the selective role of HPST in improving skin quality. Methods: A retrospective analysis was performed on 743 male patients who underwent primary UAL between 2008 and 2024. Patients were grouped by era: conventional (2008-2011), HDL (2011-2014), RDL (2015-2019), and RDL with HPST (2019-2024). Outcomes included BODY-Q satisfaction, complication severity, and revision rates. Regression, mediation, and propensity-score matching analyses were applied to identify predictors of durable satisfaction and recommendation. Results: Mean satisfaction improved across eras: 59.3 (2008-2011), 57.7 (2011-2014), 66.8 (2015-2019), and 73.8 (2019-2024). HDL patients showed the lowest durable scores despite high early ratings and were most associated with self-reported “fake abs,” which correlated with reduced BODY-Q domains. RDL produced more stable outcomes, particularly in men with BMI ≤25 and ≥4 exercise sessions/week. Sports frequency predicted higher satisfaction directly and indirectly via lower body mass index (BMI). Clinically meaningful complications declined from 15.4% to 4.6% across eras. Helium-plasma skin tightening was offered mainly to older, higher-BMI men and, after adjustment, was not independently associated with improved skin quality. RDL was linked to a lower revision risk (odds ratio (OR) 0.32, P = .029). Conclusions: Real-definition liposuction provided natural, durable outcomes and fewer revisions than HDL. Over-etching increased unnatural contours and dissatisfaction. Careful patient selection—BMI ≤25, consistent exercise, and weight stability—is critical, while HPST may be reserved for older men with mild laxity. Level of Evidence: 3 (Therapeutic):
- 1 April 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (2) , 117-121
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy
Objective: Differences in individual muscle/fat volumes may change the effectiveness of chemotherapy. In this study, the relationship between trunkal muscle and fat volume and body mass index (BMI) obtained before receiving neoadjuvant chemotherapy (NCT) in patients with breast cancer and complete pathological response (pCR) was investigated. Materials and Methods: The volumes of psoas, abdominal and paraspinal muscles, and trunkal subcutaneous and visceral fat were calculated using CoreSlicer AI 2.0 opensource program from the F-18 fluorodeoxyglucose positron emission tomography/computed tomography (CT) and CT images before NCT and postoperative pCR rates to NCT were recorded. Muscle/fat volumes and BMI prior to NCT were compared in terms of pathological pCR rates. Patients were followed up regularly for recurrence and survival. Results: Ninety-three patients were included with median (range) values for age, BMI, and body weights of 48 (28-72) years, 27 (16.8-51.6) kg/m(2), and 71.94 (43-137) kg, respectively. The median follow-up time was 18.6 (6.7-59.6) months. No significant correlation was found between total muscle or fat volumes of patients with and without pCR. BMI [26.2 (16.8-51.6) kg/m(2) vs. 24.6 (20.3-34.3) kg/m(2), p = 0.03] and pCR rates in patients with low rightpsoas muscle volume [11.74 (7.03-18.51) vs. 10.2 (6.71-13.36), p = 0.025] were significantly greater. A significant relationship was found between right psoas muscle volume and disease-free survival (DFS) (11.74 cm(3) (7.03-18.51) vs. 10.2 cm(3) (6.71-13.36), p = 0.025). However, no significant relationship was detected between total muscle-fat volume, BMI and overall survival and DFS (p>0.05). Conclusion: This is the first published study investigating the relationship between the pCR ratio and body muscle and fat volume measured by CoreSlicer AI 2.0 in patients with breast cancer who received NCT. No correlation was found between the pCR ratio and total muscle plus fat volume. However, these results need to be validated with larger patient series.
- 1 April 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (2) , 117-121
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy
Objective: Differences in individual muscle/fat volumes may change the effectiveness of chemotherapy. In this study, the relationship between trunkal muscle and fat volume and body mass index (BMI) obtained before receiving neoadjuvant chemotherapy (NCT) in patients with breast cancer and complete pathological response (pCR) was investigated. Materials and Methods: The volumes of psoas, abdominal and paraspinal muscles, and trunkal subcutaneous and visceral fat were calculated using CoreSlicer AI 2.0 opensource program from the F-18 fluorodeoxyglucose positron emission tomography/computed tomography (CT) and CT images before NCT and postoperative pCR rates to NCT were recorded. Muscle/fat volumes and BMI prior to NCT were compared in terms of pathological pCR rates. Patients were followed up regularly for recurrence and survival. Results: Ninety-three patients were included with median (range) values for age, BMI, and body weights of 48 (28-72) years, 27 (16.8-51.6) kg/m(2), and 71.94 (43-137) kg, respectively. The median follow-up time was 18.6 (6.7-59.6) months. No significant correlation was found between total muscle or fat volumes of patients with and without pCR. BMI [26.2 (16.8-51.6) kg/m(2) vs. 24.6 (20.3-34.3) kg/m(2), p = 0.03] and pCR rates in patients with low rightpsoas muscle volume [11.74 (7.03-18.51) vs. 10.2 (6.71-13.36), p = 0.025] were significantly greater. A significant relationship was found between right psoas muscle volume and disease-free survival (DFS) (11.74 cm(3) (7.03-18.51) vs. 10.2 cm(3) (6.71-13.36), p = 0.025). However, no significant relationship was detected between total muscle-fat volume, BMI and overall survival and DFS (p>0.05). Conclusion: This is the first published study investigating the relationship between the pCR ratio and body muscle and fat volume measured by CoreSlicer AI 2.0 in patients with breast cancer who received NCT. No correlation was found between the pCR ratio and total muscle plus fat volume. However, these results need to be validated with larger patient series.
- Open Access
- 23 March 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-9
Outcomes of reconstructive techniques in breast cancer using BCCT. core software
Background: Surgery remains a priority for breast cancer treatment. This study aimed to compare the cosmetic outcomes of oncoplastic patients who had undergone breast-conserving surgery, mini-LDF (latissimus dorsi flap), and immediate implant reconstruction using both the Japanese scale and the BCCT.core (The Breast Cancer Conservative Treatment cosmetic results software) program and to validate this program. Patients and methods: Patients who underwent surgery for breast cancer between 1997 and 2021 were retrospectively studied. Patients were divided into three groups: 1-those who had undergone breast-conserving surgery (245 patients, 71.3%), 2-those who had undergone mini-LDF after lumpectomy (38 patients, 11.02%), and 3- those who underwent reconstruction with implants after nipple-sparing mastectomy (61 patients, 17.68%). The patients were called for a follow-up examination, and their photos were taken. The photographs were shown to an independent breast surgeon and a plastic surgeon who was not included in the surgeries, and they were asked to evaluate and rate them according to the Japanese cosmetic evaluation scale. The same images were transferred to the computer and scored using BCCT.core. Results: The plastic and breast surgeon evaluation results showed no significant difference between the three cosmetic techniques (p = 0.99, 0.98). The results of BCCT.core software measurements were similar to the results of plastic and breast surgeons (p: 0.43). Conclusion: Patients are more knowledgeable about cosmetic outcomes and expect more objective data. In this study, we used 3 different cosmetic evaluation scales. We found that these techniques give results that are compatible with each other in terms of evaluating the work done in a more concrete way. For this reason, we recommend the use of such software, which offers objective results in a subjective field such as aesthetics and is very easy to apply.
- 23 March 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-9
Open AccessOutcomes of reconstructive techniques in breast cancer using BCCT. core software
Background: Surgery remains a priority for breast cancer treatment. This study aimed to compare the cosmetic outcomes of oncoplastic patients who had undergone breast-conserving surgery, mini-LDF (latissimus dorsi flap), and immediate implant reconstruction using both the Japanese scale and the BCCT.core (The Breast Cancer Conservative Treatment cosmetic results software) program and to validate this program. Patients and methods: Patients who underwent surgery for breast cancer between 1997 and 2021 were retrospectively studied. Patients were divided into three groups: 1-those who had undergone breast-conserving surgery (245 patients, 71.3%), 2-those who had undergone mini-LDF after lumpectomy (38 patients, 11.02%), and 3- those who underwent reconstruction with implants after nipple-sparing mastectomy (61 patients, 17.68%). The patients were called for a follow-up examination, and their photos were taken. The photographs were shown to an independent breast surgeon and a plastic surgeon who was not included in the surgeries, and they were asked to evaluate and rate them according to the Japanese cosmetic evaluation scale. The same images were transferred to the computer and scored using BCCT.core. Results: The plastic and breast surgeon evaluation results showed no significant difference between the three cosmetic techniques (p = 0.99, 0.98). The results of BCCT.core software measurements were similar to the results of plastic and breast surgeons (p: 0.43). Conclusion: Patients are more knowledgeable about cosmetic outcomes and expect more objective data. In this study, we used 3 different cosmetic evaluation scales. We found that these techniques give results that are compatible with each other in terms of evaluating the work done in a more concrete way. For this reason, we recommend the use of such software, which offers objective results in a subjective field such as aesthetics and is very easy to apply.
- Open Access
- 19 October 2023
- Published by MDPI AG in Current Oncology
- Vol. 30 (10) , 9217-9229
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in pre-menopausal women. Studies have shown that AMH levels are more sensitive than those of E2, FSH, and inhibin B and that AFC and MOV can be used to evaluate ovarian reserve. AMH, AFC, and MOV measurements were performed before and after adjuvant SC in 3-month periods for one year. Patients were classified as experiencing chemotherapy-induced amenorrhea (CIA) if they did not have menstrual cycles for a period of six months or longer following the conclusion of their chemotherapy treatment. We aimed to evaluate the factors affecting chemotherapy-induced amenorrhea in breast cancer patients treated with adjuvant chemotherapy and the performance of baseline measurements of AMH, AFC, and MOV to predict chemotherapy-induced amenorrhea. The effects of different chemotherapy regimens on the AMH level, AFC, and MOV in CIA patients were investigated. Seventy-one patients were eligible for this study, and the median age was 38 years (range: 23–45). The median follow-up was 37 months (range: 20–51), and CIA developed in 62% of the patients. The AMH level and AFC were significantly decreased one year after SC (p < 0.0001), whereas MOV was not (p = 0.507). AMH levels before chemotherapy (median: 1.520 vs. 0.755, p = 0.001) and at the end of the first year (median: 0.073 vs. 0.010, p = 0.030) and pre-treatment AFC (median: 12 vs. 4.50, p = 0.026) were lower in patients with CIA compared to those without CIA. The AMH levels before SC were the most valuable and earliest factor for predicting CIA development. In addition, there was no difference between the chemotherapy regimens (including or not including taxane) in terms of CIA development.
- 19 October 2023
- Published by MDPI AG in Current Oncology
- Vol. 30 (10) , 9217-9229
Open AccessEvaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in pre-menopausal women. Studies have shown that AMH levels are more sensitive than those of E2, FSH, and inhibin B and that AFC and MOV can be used to evaluate ovarian reserve. AMH, AFC, and MOV measurements were performed before and after adjuvant SC in 3-month periods for one year. Patients were classified as experiencing chemotherapy-induced amenorrhea (CIA) if they did not have menstrual cycles for a period of six months or longer following the conclusion of their chemotherapy treatment. We aimed to evaluate the factors affecting chemotherapy-induced amenorrhea in breast cancer patients treated with adjuvant chemotherapy and the performance of baseline measurements of AMH, AFC, and MOV to predict chemotherapy-induced amenorrhea. The effects of different chemotherapy regimens on the AMH level, AFC, and MOV in CIA patients were investigated. Seventy-one patients were eligible for this study, and the median age was 38 years (range: 23–45). The median follow-up was 37 months (range: 20–51), and CIA developed in 62% of the patients. The AMH level and AFC were significantly decreased one year after SC (p < 0.0001), whereas MOV was not (p = 0.507). AMH levels before chemotherapy (median: 1.520 vs. 0.755, p = 0.001) and at the end of the first year (median: 0.073 vs. 0.010, p = 0.030) and pre-treatment AFC (median: 12 vs. 4.50, p = 0.026) were lower in patients with CIA compared to those without CIA. The AMH levels before SC were the most valuable and earliest factor for predicting CIA development. In addition, there was no difference between the chemotherapy regimens (including or not including taxane) in terms of CIA development.
- Open Access
Comparison of Aesthetic Quality of the Final Scar in Abdominoplasty with Conventional and Mini Inverted t-Scar
Background and objectives: Abdominoplasty is one of the most commonly performed cosmetic procedures. The excess skin in the conventional abdominoplasty is transversely excised and a single horizontal scar is formed. The mini inverted t-scar abdominoplasty is a modification of the “Fleur-de-lis” technique and involves the use of a small vertical incision in comparison to the long vertical incision. The aim of this technique is to lower the position of the final abdominal scar instead of addressing the horizontal laxity. In this study, we have compared the aesthetic satisfaction, width and the position of the scar with conventional abdominoplasty and mini inverted t-scar abdominoplasty. Materials and Methods: Thirty patients undergoing abdominoplasty and breast reconstruction with transverse rectus abdominis flap (TRAM) and deep inferior epigastric flap (DIEP) were included in the study. In 15 patients, abdominal closure with the conventional transverse scar was performed. In the remaining 15 patients, closure with a mini inverted t-scar was performed. Scar width, scar height and satisfaction scores were evaluated in both groups. Results: Scar widths, scar heights and patients’ and as well as surgeons’ satisfaction scores were better in the mini inverted t-scar group than the conventional group. Conclusions: The visibility of the vertical scar alone should not be a reason to avoid mini inverse t-scar abdominoplasty. Mini inverted t-scar can be an option to achieve a better hidden high-quality scar.
Open AccessComparison of Aesthetic Quality of the Final Scar in Abdominoplasty with Conventional and Mini Inverted t-Scar
Background and objectives: Abdominoplasty is one of the most commonly performed cosmetic procedures. The excess skin in the conventional abdominoplasty is transversely excised and a single horizontal scar is formed. The mini inverted t-scar abdominoplasty is a modification of the “Fleur-de-lis” technique and involves the use of a small vertical incision in comparison to the long vertical incision. The aim of this technique is to lower the position of the final abdominal scar instead of addressing the horizontal laxity. In this study, we have compared the aesthetic satisfaction, width and the position of the scar with conventional abdominoplasty and mini inverted t-scar abdominoplasty. Materials and Methods: Thirty patients undergoing abdominoplasty and breast reconstruction with transverse rectus abdominis flap (TRAM) and deep inferior epigastric flap (DIEP) were included in the study. In 15 patients, abdominal closure with the conventional transverse scar was performed. In the remaining 15 patients, closure with a mini inverted t-scar was performed. Scar width, scar height and satisfaction scores were evaluated in both groups. Results: Scar widths, scar heights and patients’ and as well as surgeons’ satisfaction scores were better in the mini inverted t-scar group than the conventional group. Conclusions: The visibility of the vertical scar alone should not be a reason to avoid mini inverse t-scar abdominoplasty. Mini inverted t-scar can be an option to achieve a better hidden high-quality scar.
- 1 March 2019
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 13 (1) , 30-34
Squamous Cell Carcinoma of the Hand: Clinical Presentation, Surgical Treatment, Outcome and Survival Rate: a Series of 129 Cases
- 1 March 2019
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 13 (1) , 30-34
Squamous Cell Carcinoma of the Hand: Clinical Presentation, Surgical Treatment, Outcome and Survival Rate: a Series of 129 Cases
- 1 September 2018
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 81 (3) , 311-315
A New Technique in Management of Depressed Posttracheostomy Scars
Background The goals of tracheostomy scar revision are filling of the depressed area, providing easy sliding of skin over the trachea. There are various techniques described to correct this situation. In this article, a modification of split sternocleidomastoid (SCM) muscle flap used in the correction of posttracheostomy defects is described. Methods Thirteen patients who had depressed scars after tracheostomy are included in this study. The mean patient age was 44 years (range, 27–56 years). All patients who suffered from tracheal tug, dysphagia, and bad appearance are included in the study. The area with the depressed scar is de-epithelialized after incising around the depression. Bilateral SCM muscles are split in the coronal plane toward superior half of the muscle while leaving the posterior part of the muscle attached to the bone. After elevation, both SCM muscle flaps are overlapped in the midline. Results The mean follow-up period of the patients was 11 months (range, 5–20 months). Tracheal tug and dysphagia complaints were resolved in all patients. The depressed area due to the scar was either reduced or completely recovered in all the patients. Apart from 1 hematoma case, none of the early or late complications such as infection, wound dehiscence, skin necrosis, seroma, recurrence, or neck contracture was seen. Conclusions We think that this technique, which gives functionally and aesthetically satisfying results, can be used safely in depressed scars formed after tracheostomy and treatment of functional impairment due to this procedure.
- 1 September 2018
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 81 (3) , 311-315
A New Technique in Management of Depressed Posttracheostomy Scars
Background The goals of tracheostomy scar revision are filling of the depressed area, providing easy sliding of skin over the trachea. There are various techniques described to correct this situation. In this article, a modification of split sternocleidomastoid (SCM) muscle flap used in the correction of posttracheostomy defects is described. Methods Thirteen patients who had depressed scars after tracheostomy are included in this study. The mean patient age was 44 years (range, 27–56 years). All patients who suffered from tracheal tug, dysphagia, and bad appearance are included in the study. The area with the depressed scar is de-epithelialized after incising around the depression. Bilateral SCM muscles are split in the coronal plane toward superior half of the muscle while leaving the posterior part of the muscle attached to the bone. After elevation, both SCM muscle flaps are overlapped in the midline. Results The mean follow-up period of the patients was 11 months (range, 5–20 months). Tracheal tug and dysphagia complaints were resolved in all patients. The depressed area due to the scar was either reduced or completely recovered in all the patients. Apart from 1 hematoma case, none of the early or late complications such as infection, wound dehiscence, skin necrosis, seroma, recurrence, or neck contracture was seen. Conclusions We think that this technique, which gives functionally and aesthetically satisfying results, can be used safely in depressed scars formed after tracheostomy and treatment of functional impairment due to this procedure.